Skip to main content

Group II GBCM Can Be Used Safely for Imaging in Stage 4/5 CKD Patients: CON.

Publication ,  Journal Article
Pun, PH; Crowley, ST
Published in: Kidney360
January 28, 2021

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Kidney360

DOI

EISSN

2641-7650

Publication Date

January 28, 2021

Volume

2

Issue

1

Start / End Page

13 / 15

Location

United States

Related Subject Headings

  • Renal Insufficiency, Chronic
  • Nephrogenic Fibrosing Dermopathy
  • Humans
  • Gadolinium
  • Contrast Media
  • 4202 Epidemiology
  • 3202 Clinical sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Pun, P. H., & Crowley, S. T. (2021). Group II GBCM Can Be Used Safely for Imaging in Stage 4/5 CKD Patients: CON. Kidney360, 2(1), 13–15. https://doi.org/10.34067/KID.0005572020
Pun, Patrick H., and Susan T. Crowley. “Group II GBCM Can Be Used Safely for Imaging in Stage 4/5 CKD Patients: CON.Kidney360 2, no. 1 (January 28, 2021): 13–15. https://doi.org/10.34067/KID.0005572020.
Pun PH, Crowley ST. Group II GBCM Can Be Used Safely for Imaging in Stage 4/5 CKD Patients: CON. Kidney360. 2021 Jan 28;2(1):13–5.
Pun, Patrick H., and Susan T. Crowley. “Group II GBCM Can Be Used Safely for Imaging in Stage 4/5 CKD Patients: CON.Kidney360, vol. 2, no. 1, Jan. 2021, pp. 13–15. Pubmed, doi:10.34067/KID.0005572020.
Pun PH, Crowley ST. Group II GBCM Can Be Used Safely for Imaging in Stage 4/5 CKD Patients: CON. Kidney360. 2021 Jan 28;2(1):13–15.

Published In

Kidney360

DOI

EISSN

2641-7650

Publication Date

January 28, 2021

Volume

2

Issue

1

Start / End Page

13 / 15

Location

United States

Related Subject Headings

  • Renal Insufficiency, Chronic
  • Nephrogenic Fibrosing Dermopathy
  • Humans
  • Gadolinium
  • Contrast Media
  • 4202 Epidemiology
  • 3202 Clinical sciences